Application of Nanoemulsions in Breast Cancer Treatment

Abstract

A new, efficient, and secure clinical approach is increasingly being sought for the treatment of cancer. Nanoemulsions (NE) are projected to have a profound effect on delivering improved healthcare services with significant implications on forthcoming healthcare policies. In contrast to other drug carriers, the key value of NEs is that they can be engineered to target tumor cells and overcome the major challenge of multi-drug resistance. Multifunctional NEs are being investigated by researchers in various fields of study, primarily in the treatment of different forms of cancer. The congruent presence of NEs with contrast agents or certain dyes increases the accuracy of cancer status identification by enhancing the responsiveness of the agents; thus, they are finding application as nanotheranostics. A summary of different NEs and their documented applications in cancer therapeutics, with emphasis on breast cancer, is presented in this chapter.

A review of FDA approved drugs and their formulations for the treatment of breast cancer

“…In addition, they may be considered as a substitute for liposomes and other vesicles as well (Park et al, 2022). Nanoemulsion are now-adays considered as one of the promising formulations to achieve safe and effective cancer treatment (Verma et al, 2016;Nirmala et al, 2022). These formulations not only solve the problems related to water solubility issues (Verma et al, 2016;Barradas and de Holanda e Silva, 2021), but also can be customized for targeted cancer treatment (Song et al, 2020;Kaur et al, 2022).…”